Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2018

Apr 19, 2018

30561_dirs_2018-04-18_b398d622-ae4d-4e86-a1dd-28b4e642bafc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2018-04-16

Reporting Person: WYSZOMIERSKI JACK L (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-04-16 Common Stock M 15000 $7.97 Acquired 93803 Direct
2018-04-16 Common Stock M 15000 $11.66 Acquired 108803 Direct
2018-04-16 Common Stock S 14959 $20.25 Disposed 93844 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-04-16 Option (right to buy) $7.97 M 15000 Disposed 2018-05-01 Common Stock (15000.0) Direct
2018-04-16 Option (right to buy) $11.66 M 15000 Disposed 2018-05-18 Common Stock (15000.0) Direct

Footnotes

F1: Includes 5,843 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

F2: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2018.

F3: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $20.04 to $20.74. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.

F4: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 2, 2008.

F5: The option, representing the right to purchase a total of 15,000 shares of Exelixis, Inc. common stock, became fully exercisable on May 19, 2011.